ACE and type 2 diabetes nephropathy: Recently, combined intervention with CHOP-antisense oligonucleotides and angiotensin-converting enzyme inhibition reduced glomerular and tubular damage in type 2 diabetic nephropathy in db/db mice45, in keeping with the result in CHOP KO mice44.